Mitofusins as determinants of the resistance of glioblastoma multiforme cells to doxorubicin

2021/41/N/NZ3/02823

Keywords

Descriptors

  • NZ3_001: Biologia komórki
  • NZ3_002: Fizjologia komórki

Panel

NZ3 – Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology

Host institution

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Maciej Łukasz Pudełek

Number of co-investigators in the project: 2

Call

PRELUDIUM 20 – announced on 2021-03-15

Amount awarded
207 101 PLN
Project start date
2022-01-13
Project end date
2026-01-12
Project duration
48 months (the same as in the proposal)
Project status
Project completed

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. Metabolic reprogramming of poly(morpho)nuclear giant cells determines glioblastoma recovery from doxorubicin-induced stress

    Authors:
    Maciej Pudełek, Damian Ryszawy, Katarzyna Piwowarczyk, Sławomir Lasota, Zbigniew Madeja, Sylwia Kędracka-Krok, Jarosław Czyż
    Academic press:
    Journal of Translational Medicine (year: 2024, volume: 22, pages: nie dotyczy), Publisher: BMC, Springer Nature
    Status:
    Published
    DOI:
    10.1186/s12967-024-05541-9 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski